Michael Nyika Andrew, MD, M.P.H, attained his Master s in Public Health and Doctorate in Medicine from the College of Human Medicine in 2020. Currently, he is in the process of concluding his residency training in Physical Medicine and Rehabilitation at Spaulding Rehabilitation Hospital/Harvard Medical School.
Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig’s disease is a neurodegenerative condition that causes damage to cells in the brain and spinal cord that is essential for movement.
A team of researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and Massachusetts General Hospital (MGH) has developed a soft robotic wearable capable of significantly assisting upper arm and shoulder movement in people with ALS.
The Cullen Education and Research Fund announced the recipients of the first CERF Medical Engineering Prize for ALS Research: Dr. Leigh Hochberg, Dr. Conor Walsh, and Dr. Sabrina Paganoni.
BOSTON, Feb. 07, 2022 PathMaker Neurosystems Inc. , a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological.